Skip to main content
Fig. 5 | Pediatric Rheumatology

Fig. 5

From: Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study

Fig. 5

Pharmacokinetics of abatacept. Pharmacokinetics of abatacept were evaluated during the short-term period, to Week 16 at indicated time points (all treated patients; N = 20). Data are shown as mean (SD) for Ctrough (closed circles, left axis) and Cmax (open circles, right axis). Ctrough predose observed serum concentration, Cmax maximum observed serum concentration, SD standard deviation

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096